News | November 28, 2024
Senores Pharmaceuticals launches Ivermectin Tablets in US with Dr. Reddy's Laboratories
The product will be marketed by Dr. Reddy's
The product will be marketed by Dr. Reddy's
Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR
This strategic alliance is aimed at strengthening hospital systems and developing advanced AMR interventions
The initiative will encourage and motivate emerging biotech startups, innovators and entrepreneurs
New research labs and process development services to enable next generation therapeutics
Performed within GENEWIZ from Azenta Life Sciences' CLIA-certified and CAP-accredited state-of-the-art clinical genomics laboratory
Emcure has launched an awareness campaign to help spread the word about male anemia
Modernization and supply chain diversity drive new growth
Launch of new product range aligns with strategy to diversify into emerging applications with high growth potential
The MoU signed in 2022 has progressed and culminated in the subsumption of FOGSI-led Manyata initiative’s 20 quality standards across NABH’s Certification programs
Subscribe To Our Newsletter & Stay Updated
